Delivery Order SPE2DB22D1017-SPE2DB25FF4CH
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,006.48 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a drug used in the management of diabetes. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.81 firm fixed-price delivery order covers the supply of 4566878224 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has an ultimate completion date of January 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,204.31 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used for diabetes management. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,741.99, is a delivery order for the supply of Dapagliflozin 10 mg tablets. It has a firm fixed price and an ultimate completion date of August 26, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $55,796.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566824454 - DAPAGLIFLOZIN 10 MG TABLET 30S, with a period of performance through January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,932.76 firm fixed price delivery order is for the supply of 4,566,177,485 dapagliflozin 10 mg tablets. The award has an ultimate completion date of October 23, 2024 and was made on October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, with a ceiling value of $5,772.53 and a period of performance through January 31, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,477.65, is for the delivery of 4567090934 - DAPAGLIFLOZIN 10 MG TABLET 30S. It is a firm fixed-price delivery order contract with a completion date of January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,203.65 firm fixed-price delivery order is for the supply of 4,566,715,316 tablets of the prescription medication dapagliflozin 10 mg, with a final completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566963944 - Dapagliflozin 10 mg tablets. The contract has a ceiling value of $9,010.19 and is a firm fixed-price delivery order with a completion date of January 17, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...